Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.
about
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nilotinib as frontline and sec ...... loid leukemia: open questions.
@en
Nilotinib as frontline and sec ...... loid leukemia: open questions.
@nl
type
label
Nilotinib as frontline and sec ...... loid leukemia: open questions.
@en
Nilotinib as frontline and sec ...... loid leukemia: open questions.
@nl
prefLabel
Nilotinib as frontline and sec ...... loid leukemia: open questions.
@en
Nilotinib as frontline and sec ...... loid leukemia: open questions.
@nl
P2093
P1476
Nilotinib as frontline and sec ...... eloid leukemia: open questions
@en
P2093
Alois Lang
Andreas L Petzer
Dominik Wolf
Elisabeth Pittermann
Günther Gastl
Josef Thaler
Klaus Geissler
Lisa Pleyer
Richard Greil
Thomas Lion
P304
P356
10.1016/J.CRITREVONC.2011.08.002
P577
2011-09-07T00:00:00Z